The S&P 500 has dropped 3.8% since the end of July, but that's nothing compared to the losses we've seen from biotech stocks.
In fact,...
For biotech stock investors, what happened to Aquanox Pharmaceuticals Inc. (Nasdaq: AQXP) over the past week looked like the ultimate fantasy come...
On Jan. 7, 2015, CytRX Corp. announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and...
Biotech investing can be tricky. The industry is complicated, and the stocks are volatile.
But the profit payoff can be life-changing....
Weight loss is a $20 billion per year industry. Yet, it seems the more we spend on shedding pounds, the more pounds we have to...
When you're evaluating most new stocks, it makes good sense to look at technical indicators - such as price-to-earnings ratio (P/E), profit...
Editor's Note: We're sharing this Private Briefing with you because it contains a pick that's put Bill's readers up as much as 444%...
Today I want to reintroduce you to a biotech stock that Wall Street has been pricing as though it were dead money.
This biotech company...
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics,...
It's a common thought that investing in biotech stocks is just too risky for the average investor - but that's not the case.
It's true...
Some analysts feel that the biotech sector's recent tumble is evidence of the biotech bubble bursting.
How do single-day stock gains of 40%, 50%, 75%, even a 100% or more sound? If you're anything like me they sound pretty darn great....
When you're evaluating a biotech, or even a full-fledged pharmaceutical company, you'll want to look at its product pipeline, upcoming catalysts,...
Biotech stocks have delivered a healthy dose of returns to investors...
Anyone who's very familiar with the bioscience/pharmaceutical sector will tell you investing in experimental drugs can be an object lesson in...
What a year so far for biotech stock profits...
Another consolidation in the active biotech sector came Tuesday when Cadence ...
This could be the biggest year ever for investing in biotech takeover targets - all due to the patent cliff.
The "patent cliff" refers...
IPO Calendar 2014: This year is forecast to be a record year for initial public offerings (IPOs).
Over the...
If there's one sector that's primed for explosive growth right now, it's biotechnology.
Its position as a new market leader in the...
Biotech stocks are soaring in 2013 as major innovations in healthcare have offered enormous breakthroughs on once-untreatable diseases and ...
